Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Transl Neurodegener. 2013 Jan 25;2(1):2. doi: 10.1186/2047-9158-2-2.

Translational research in Huntington's disease: opening up for disease modifying treatment.

Author information

  • Swiss Huntington's Disease Centre, Department of Neurology, University of Bern, Neurobu Clinics, Steinerstrasse 45, CH 3006, Bern, Switzerland. Jean-marc.burgunder@dkf.unibe.ch.

Abstract

Research on the molecular mechanisms involved in Huntington's disease, a monogenic disorder with a complex phenotype including motor, behaviour, and cognitive impairments, is advancing at a rapid path. Knowledge on several of the multimodal pathways has now lead to the establishment of rational strategies to prepare trials of several compounds in affected people. Furthermore, improved understanding of the phenotype and on ways of assessing it, as well as the process of developing biomarkers, allows setting the frame for such studies. In this brief review, the present status of some of these aspects is examined.

PMID:
23347646
[PubMed]
PMCID:
PMC3610231
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk